- By Ely Marquez
- (General Dispatch) – According to a Danish media, the AstraZeneca vaccine will be under investigation for three more weeks after side effects were reported in vaccinated people.
- Denmark suspended the AstraZeneca vaccine on March 11 after a 60-year-old patient was immunized and days later developed blood clots throughout her body, leading to her death.
- Another death occurred later, but the authorities did not say that the cause was directly due to the effects of the vaccine, and as a precaution they opted to suspend the vaccination until diagnostic results were found.
- The AstraZeneca vaccine has been the one that has been supplied in greater quantity to different nations due to its easy transportation and cost, the United Kingdom has immunized most of its population, but they have had minimal cases of blood clots.
- Sweden and Norway had suspended its distribution, but with no more cases of blood clots and the approval of different countries in Europe, they gave the authorization to resume its application.
- The AstraZeneca vaccine has been in great demand, even the European Commission has had problems to distribute it due to contractual problems, and less than 10% of the European population has not been immunized.
- The European Medicines Agency reported in a statement that the benefits of the vaccine outweigh the side effects, which may be generated by other types of conditions that the patient suffers from.
- Soeren Brostroem, head of the Danish Health Agency said, “At this stage, we believe that our basis for making a final decision on the future use of the COVID-19 vaccine by AstraZeneca is too uncertain,” but for now the government is expected to reauthorize its application.
Adittional Information:
Breitbart: Denmark Extends AstraZeneca Suspension to Evaluate Possible Side Effects
New Sky: COVID-19: Denmark extends suspension of the AstraZeneca vaccine for 3 weeks
